Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Driving launch excellence with agile transformation

Examining the key risks and opportunities that biopharma asset teams should prioritise during R&D and launch

Amiculum - science that speaks volumes

New brand, same great team!

We’re excited to launch our refreshed Amiculum visual identity today. Our new brand encapsulates the vibrancy and creativity that we see every day from our team. It’s fresh, forward-looking and...

Amiculum

- PMLiVE

New study highlights global overuse of antibiotics for diverticulitis

Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

- PMLiVE

Havas Life London appoints Fran Griffin as Head of Strategy

Griffin moves from BBH London to Havas Health

- PMLiVE

The Rashomon Effect

Why your cross-functional team gets cross

- PMLiVE

Stories of sickness: applying illness narratives to health advertising

By Dr Stephanie Goley Introduction As advertisers, we know that health and pharmaceutical campaigns hold enormous influence over how the public perceives illness, wellness, and treatment. But too often, our...

11 London

Young girl receives vaccine jab in her arm

Regaining trust in childhood vaccines: can better comms turn the tables on hesitancy and misinformation?

In the wake of Trump questioning MMR vaccines, we review the best practices in vaccine communications and consider how to reverse damage done to public trust in childhood vaccinations.

Say Communications

- PMLiVE

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Medscape Education

- PMLiVE

PMLiVE’s T40 – now open for submissions!

Healthcare agencies can submit their entries free of charge with a deadline of 30 October

- PMLiVE

Roche’s small cell lung cancer therapy approved by FDA

This is the first and only approved combination therapy for extensive-stage small cell lung cancer

- PMLiVE

Indegene acquires BioPharm to advance AI-driven life sciences marketing

The acquisition strengthens Indegene’s AI-enabled commercialisation and AdTech capabilities

- PMLiVE

The impact of US tariffs on healthcare and life sciences multinationals

Ensuring business continuity across clinical, operational and commercial stages

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links